Bisophosphonates in the treatment of osteoporosis in women with breast cancer

Bisophosphonates in the treatment of osteoporosis in women with breast cancer

Diğer sürümleri göster (1)

Abstract Osteoporosis is the most common skeletal disorder. It is characterized by a decrease in bone density, which results in a greater likelihood of hip, vertebral and long bone fractures. Women who are undergoing hormonal treatment for hormone-related breast cancer are particularly at risk for...

Detaylı Bibliyografya
Yazar:	Joanna Wolska
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Kazimierz Wielki University 2019-09-01
Seri Bilgileri:	Journal of Education, Health and Sport
Konular:	breast cancer osteoporosis bisphosphonates
Online Erişim:	https://apcz.umk.pl/JEHS/article/view/27337

Benzer Materyaller

Bisophosphonates in the treatment of osteoporosis in women with breast cancer
Yazar:: Joanna Wolska
Baskı/Yayın Bilgisi: (2019-09-01)

Association of Antiosteoporotic Medication Bisphosphonates and Denosumab with Primary Breast Cancer: An Electronic Health Record Cohort Study
Yazar:: Alexander Stanoyevitch, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Current treatment of osteoporosis
Yazar:: Subramanian Nallasivan
Baskı/Yayın Bilgisi: (2019-01-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
Yazar:: İlke Coşkun Benlidayı, ve diğerleri
Baskı/Yayın Bilgisi: (2015-08-01)

Osteoporosis in women in menopause/postmenopause: what to do?
Yazar:: E. V. Kulchavenya, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Drug Holiday in Osteoporosis
Yazar:: Annil Mahajan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Drug Holiday in Osteoporosis
Yazar:: Annil Mahajan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Yazar:: Peyman Hadji, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
Yazar:: Ahmet Aslan, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

Prospective clinical study of once monthly ibandronate in the treatment of osteoporosis and prevention of fractures in postmenopausal women: Orpheum study
Yazar:: Bumbaširević Marko, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

New approaches to osteoporosis in primary care
Yazar:: Mihaela Daniela BALTĂ, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)
Yazar:: Christian Meier, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Indications to teriparatide treatment in patients with osteoporosis
Yazar:: R Rizzoli, ve diğerleri
Baskı/Yayın Bilgisi: (2011-11-01)

Treatment of osteoporosis with teriparatide: The Slovenian experience
Yazar:: Kocjan Tomaz, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Osteoporosis – pathophysiology, symptoms, prevention and treatment
Yazar:: Agnieszka Dobosz, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Current concept of osteoporosis diagnosis and treatment in children
Yazar:: Natalia V. Toroptsova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Long-term Treatment with Bisphosphonates and Their Side Effects in Postmenopausal Osteoporosis - Review
Yazar:: Merih Sarıdoğan, ve diğerleri
Baskı/Yayın Bilgisi: (2010-12-01)

Long-term use of Bonviva for the treatment of postmenopausal osteoporosis: new evidence
Yazar:: Olga Borisovna Yershova, ve diğerleri
Baskı/Yayın Bilgisi: (2012-03-01)

Cancer treatment-induced bone loss
Yazar:: Yong Jun Choi
Baskı/Yayın Bilgisi: (2024-09-01)

Assessment of the Admission and Follow-up Characteristics of Children Diagnosed with Secondary Osteoporosis
Yazar:: Emine Kübra Şen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Pharmacological therapy of osteoporosis with bisphosphonates – for whom, what kind, and for how long?
Yazar:: Ewa Marcinowska-Suchowierska, ve diğerleri
Baskı/Yayın Bilgisi: (2014-09-01)

Treatment of osteoporosis in patients who had low-energy fractures: challenges of diagnosis and commitment to pathogenetic treatment
Yazar:: O. V. Dobrovolskaya, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Multidisciplinary approach to osteoporosis management
Yazar:: Atul Kakar, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Yazar:: N V Seredavkina, ve diğerleri
Baskı/Yayın Bilgisi: (2009-12-01)

Alendronate improves QOL of postmenopausal women with osteoporosis
Yazar:: Hisaya Kawate, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Treatment of primary osteoporosis in men
Yazar:: Giusti A, ve diğerleri
Baskı/Yayın Bilgisi: (2014-12-01)

Ibandronate Treatment Before and After Implant Insertion Impairs Osseointegration in Aged Rats with Ovariectomy Induced Osteoporosis
Yazar:: Ethan M. Lotz, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
Yazar:: Calabria S, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

A Novel Disorder of Osteoporosis, Osteonecrosis, and Metaphyseal Fracture
Yazar:: Hans‐Georg Zmierczak, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Pediatric osteoporosis: An update
Yazar:: Aylin Günay, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Evaluation of some biomarkers of osteoporosis in women with breast cancer in Al-Najaf Governorate
Yazar:: Sarah Mohammed Hussein AL-Thabhawee
Baskı/Yayın Bilgisi: (2023-12-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
Yazar:: Nataliya Vladimirovna Toroptsova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
Yazar:: Nataliya Vladimirovna Toroptsova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
Yazar:: Victor G Vogel
Baskı/Yayın Bilgisi: (2008-12-01)

Back pain and spinal osteoporosis in clinical practice
Yazar:: N. V. Pizova, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Periapical status in patients affected by osteoporosis: A retrospective clinical study
Yazar:: Erika Cadoni, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Search for genetic markers determining the efficiency of therapy with bisphosphonates in Russian women with postmenopausal osteoporosis: A pilot study
Yazar:: M. Yu. Krylov, ve diğerleri
Baskı/Yayın Bilgisi: (2016-10-01)

Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review
Yazar:: Eric D. Van Baarsel, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Treatment of postmenopausal osteoporosis: a literature-based algorithm for use in the public health care system
Yazar:: Ellen Luz Pereira Caires, ve diğerleri

The use of bisphosphonates for the treatment and prevention of osteoporosis
Yazar:: O. A. Nikitinskaya, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)